These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling. Vecchio EA, Chuo CH, Baltos JA, Ford L, Scammells PJ, Wang BH, Christopoulos A, White PJ, May LT. Biochem Pharmacol; 2016 Oct 01; 117():46-56. PubMed ID: 27520486 [Abstract] [Full Text] [Related]
10. Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors. Ji XD, Jacobson KA. Drug Des Discov; 1999 Nov 01; 16(3):217-26. PubMed ID: 10624567 [Abstract] [Full Text] [Related]
11. A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives. Vittori S, Costanzi S, Lambertucci C, Portino FR, Taffi S, Volpini R, Klotz KN, Cristalli G. Nucleosides Nucleotides Nucleic Acids; 2004 Nov 01; 23(1-2):471-81. PubMed ID: 15043167 [Abstract] [Full Text] [Related]
12. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor. Klotz KN, Falgner N, Kachler S, Lambertucci C, Vittori S, Volpini R, Cristalli G. Eur J Pharmacol; 2007 Feb 05; 556(1-3):14-8. PubMed ID: 17126322 [Abstract] [Full Text] [Related]
19. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000. Gao ZG, Ye K, Göblyös A, Ijzerman AP, Jacobson KA. BMC Pharmacol; 2008 Dec 12; 8():20. PubMed ID: 19077268 [Abstract] [Full Text] [Related]